"","Num","POD","SD","%","Genes","KE"
"RESPONSE TO REACTIVE OXYGEN SPECIES","3","0.000131886651621274","0.10176153302304","5.36","anxa1a, cyp2y3, sod1","INCREASED REACTIVE OXYGEN SPECIES"
"GO:0019226","3","0.00508476164241159","0.900353191591311","25","chrna1, scn1lab, sod1","REDUCTION ECDYSIS MOTONEURON BURSTS"
"ABNORMALITY OF THE BLADDER","6","0.0144700601893187","0.31122075296401","11.54","aldh18a1, cdc45, glud1a, plod1a, scn1lab, smo","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0050663","3","0.0164097513301614","1.06932131901542","10","anxa1a, caspa, tmsb4x","RELEASE CYTOKINE"
"GO:0006629","10","0.0232225149421569","0.260319571741159","4.85","acadl, anxa1a, cyp2y3, fgfr4, hsd11b2, ndufs6, pck2, per2, sirt3, sod1","ALTERATION LIPID METABOLISM"
"GO:0016209","2","0.0379040939760422","1.87071867200475","18.18","gsr, sod1","OXIDATION GLUTATHIONE"
"GLUTATHIONE METABOLIC PROCESS","2","0.0379040939760422","1.87071867200475","20","gsr, sod1","GLUTATHIONE SYNTHESIS; GLUTATHIONE HOMEOSTASIS"
"CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R","2","0.0393898293992364","1.4054785091482","15.38","fgfr4, igf1ra","INCREASED IGF-1 MOUSE"
"GO:0009611","6","0.0413306315628633","0.498261294937321","5.36","anxa1a, erbb2, gli1, pdx1, smad2, sod1","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0000003","9","0.0566305250861107","0.278336189573075","4.43","adcyap1b, anxa1a, gli1, gli2a, hsd11b2, igf2a, sod1, tcf7, thrb","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0001816","7","0.0783861412187551","0.364839654443532","5.83","adcyap1b, anxa1a, caspa, polr3f, polr3h, sod1, tmsb4x","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0006954","9","0.0885117062088926","0.290235152342749","7.69","adcyap1b, anxa1a, caspa, ogg1, scn1lab, smo, sod1, tmsb4x, vcam1","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0044703","5","0.0919637806182531","0.564839558589652","4.31","adcyap1b, gli1, hsd11b2, sod1, thrb","N/A REPRODUCTIVE FAILURE"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","10","0.106934922080088","0.211783174910697","2.48","cyp2y3, gli1, gsr, mcm4, pdx1, plod1a, rps10, scn1lab, smo, tpi1b","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"PARALYSIS","5","0.109705357213268","0.531947426486998","21.74","aldh18a1, pola1, scn1lab, sod1, tpi1b","INDUCTION SOMATIC MUSCLE PARALYSIS; INDUCTION PHARYNGEAL MUSCLE PARALYSIS"
"GO:0048870","7","0.128584720667696","0.36581822557851","3.5","anxa1a, erbb2, fgfr4, igf1ra, smo, tmsb4x, vcam1","INCREASED MOTILITY"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","13","0.130363372167899","0.159244756478929","8.84","aldh18a1, cdc45, chrna1, gli1, gli2a, mcm4, plod1a, pola1, polr3h, scn1lab, smo, sod1, unga","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0009790","9","0.165830826250324","0.25622883819388","5.33","gli1, gli2a, igf2a, pdx1, smad1, smad2, smo, sod1, tcf7","DEFECT OF EMBRYOGENESIS"
"GO:0006936","5","0.189303989394356","0.576490389404459","9.09","chrna1, eno1a, ndufs6, scn1lab, sod1","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0050673","3","0.192025040396668","1.00234737015643","3.66","erbb2, gli1, smo","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"HYPERACTIVITY","5","0.22439888108787","0.550088885770394","10","gli2a, glud1a, pola1, scn1lab, thrb","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"ABNORMAL LUNG MORPHOLOGY","12","0.24006435736289","0.159818592291636","9.38","aldh18a1, cdc45, chrna1, gli1, gli2a, mcm4, plod1a, pola1, polr3h, scn1lab, smo, unga","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"UPPER MOTOR NEURON DYSFUNCTION","7","0.279672348724932","0.326226875029471","1.48","aldh18a1, gli2a, pola1, scn1lab, smo, sod1, tpi1b","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"GO:0046903","14","0.352816449886324","0.178854106311591","6.06","adcyap1b, anxa1a, atp6v0ca, caspa, cfd, glud1a, igf2a, pdx1, per2, ptprb, sirt3, smad2, sod1, tmsb4x","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0040011","10","0.366174264490787","0.221723859245177","4.41","anxa1a, erbb2, fgfr4, gli2a, igf1ra, plp2, rpl24, smo, tmsb4x, vcam1","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0005515","6","0.408488491942883","0.443009322726384","12.77","fgfr4, gli1, smad2, ta, thrb, vegfaa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"ABNORMAL LIVER MORPHOLOGY","3","0.421466541407567","0.785015589672512","2.52","mcm4, ndufs6, pck2","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMAL NASAL MORPHOLOGY","7","0.515432017546965","0.268294861238455","4.52","gli2a, igf1ra, plod1a, prpf4, rps10, scn1lab, smo","INCREASE SITE OF CONTACT NASAL TUMORS"
"POSITIVE REGULATION OF GENE EXPRESSION","12","0.579318497909836","0.187409845284302","6.63","adcyap1b, anxa1a, caspa, eno1a, erbb2, fgfr4, polr3f, polr3h, smad1, smo, sod1, vegfaa","ALTERED GENE EXPRESSION"
"DECREASED BODY WEIGHT","12","0.658469320094226","0.169085332614618","5.31","aldh18a1, cdc45, gli1, gli2a, hsd11b2, igf1ra, ndufs6, pdx1, pola1, rps10, scn1lab, thrb","DECREASED BODY WEIGHT"
"GO:0042060","3","0.710464936591476","1.1253451997512","3.41","anxa1a, erbb2, smad2","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"GO:0046562","3","0.747460378109874","0.864970310533661","11.11","eno1a, pck2, tpi1b","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"GO:0016310","4","0.764207866054558","0.560683460637684","3.2","aldh18a1, erbb2, fgfr4, igf1ra","ACTIVATION SP1"
"GO:0001775","13","0.886915326874205","0.168891737001181","6.63","anxa1a, atp6v0ca, cfd, erbb2, gli2a, igf2a, prmt5, ptprb, smo, sod1, tcf7, unga, vcam1","ACTIVATION DENDRITIC CELLS"
"ABNORMALITY OF THE ABDOMINAL ORGANS","5","0.977158075744451","0.349437891288606","2.96","mcm4, ndufs6, pck2, pdx1, tpi1b","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","5","0.977158075744451","0.349437891288606","0.67","mcm4, ndufs6, pck2, pdx1, tpi1b","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"GO:0006281","5","1.29681973950925","0.310189156989053","5.88","cdc45, mcm4, ogg1, pola1, unga","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"REGULATION OF CELL DEATH","13","1.31025244465936","0.150263579219593","4.85","adcyap1b, anxa1a, caspa, eif2s1b, eno1a, gli2a, igf1ra, ogg1, pdx1, smo, sod1, unga, vegfaa","N/A CELL INJURY/DEATH"
"GO:0072358","6","1.37893932326901","0.352186241650904","5.41","anxa1a, erbb2, ndufs6, ptprb, smad1, smo","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0005102","9","1.38825848591328","0.246606099979847","4.33","adcyap1b, adrb1, anxa1a, erbb2, igf1ra, igf2a, smad2, smo, vcam1","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0005488","63","1.6491385694408","0.027746474278437","5.86","acadl, adcyap1b, adrb1, aldh18a1, anxa1a, atp5g3a, bcl2a, caspa, cdc45, chrna1, cyc1, cyp2y3, dnaja2, eif2s1b, eif4e2rs1, eno1a, erbb2, fgfr4, fzd7a, gli1, gli2a, gsr, igf1ra, igf2a, mcm4, nup35, nvl, ogg1, orc3, pck2, pdx1, per2, plod1a, pola1, polr3h, pparaa, prpf4, psmd4b, ptpn4b, ptprb, rpl24, rpl7a, rps10, rxrab, sf3a1, sirt3, smad1, smad2, smo, snrpc, sod1, ssbp1, ta, tcf7, thrb, timp2b, tmsb4x, tpi1b, u2af2b, ube2d1a, ube2ia, usf1l, vegfaa","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"REGULATION OF PROTEOLYSIS","4","1.73860000481745","0.624991794010135","3.57","caspa, eno1a, fgfr4, vegfaa","IMPAIRED PROTEOSTASIS"
"GO:0004872","13","1.83909799256221","0.12788707339747","5.44","adcyap1b, adrb1, chrna1, erbb2, fgfr4, fzd7a, igf1ra, igf2a, pparaa, rxrab, smo, thrb, vegfaa","ACTIVATION PXR/SXR"
"PYRUVATE METABOLIC PROCESS","5","1.84299762335413","0.38693172396742","8.93","eno1a, nup35, nup50, pck2, tpi1b","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"ABNORMAL CIRCULATING ESTROGEN LEVEL","2","2.02965622494139","0.0492722721285158","14.29","polr3h, smo","INCREASED CIRCULATING ESTROGEN LEVELS"
"GO:0046983","14","2.13183399310409","0.152519409257519","7.11","adrb1, anxa1a, eno1a, erbb2, gstm, nudt5, nup35, pdx1, plod1a, prmt5, smad2, snrpc, sod1, tpi1b","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"HEART DEVELOPMENT","8","2.80425754697324","0.242983710828096","6.35","erbb2, gli1, gli2a, smad1, smad2, smo, vcam1, vegfaa","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","3","2.84437763167564","0.0624884804196573","3.26","hsd11b2, mcm4, smo","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"ABNORMAL HYPOTHALAMUS PHYSIOLOGY","2","2.90204247246834","0.159072717592978","22.22","gli2a, smo","REDUCED PROSTAGLANDIN E2 CONCENTRATION HYPOTHALAMUS; DECREASE E2 BLOOD CONCENTRATIONS AT HYPOTHALAMUS"
"ABNORMAL PROLACTIN LEVEL","2","2.90204247246834","0.159072717592978","25","gli2a, smo","DECREASED PROLACTIN"
"PEPTIDYL LYSINE MODIFICATION","5","3.08052909172711","0.31187344001649","7.04","nup35, nup50, plod1a, sirt3, ube2ia","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"GO:0048856","2","3.67546488095015","0.0125289363326912","16.67","igf1ra, rxrab","ALTERED NEUROANATOMY"
"GO:0007568","7","3.88903693244295","0.305462405375548","8.14","eif2s1b, ndufs6, ogg1, pdx1, sirt3, sod1, vcam1","ACCELERATED AGING"
"GO:0003824","3","5.98374605019168","0.043508423144304","4.62","aldh18a1, ogg1, tpi1b","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0030154","4","6.12580846694448","0.182604829978492","6.15","pparaa, rxrab, thrb, vegfaa","DIFFERENTIATION OF MYOFIBROBLAST"
"GO:0016055","3","7.37220790414934","0.144709374985093","13.04","fzd7a, ta, tcf7","ALTERATION WNT PATHWAY"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","5","7.7222757336195","0.129133600242494","4.85","gli2a, pola1, polr3h, prpf4, smo","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"BREAST CANCER PATHWAY","3","8.18797264059907","0.227322787328518","2.63","erbb2, igf1ra, tcf7","N/A BREAST CANCER"
"CYTOPLASMIC RIBOSOMAL PROTEINS","3","8.27090385433245","0.138143778368849","2.08","rpl24, rpl7a, rps10","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"ABNORMALITY OF THE PITUITARY GLAND","5","8.4082146695119","0.140777734040734","10.42","gli2a, pola1, polr3h, smo, thrb","INCREASED ADENOMAS PITUITARY"
"GO:0008213","2","9.51814863339322","0.581320147777792","28.57","prmt5, unga","ALKYLATION PROTEIN"
"ELECTRON TRANSPORT CHAIN","3","12.0150921734808","0.129021222916137","4.41","cyc1, gsr, ndufs6","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0019932","4","12.1915431266596","0.195083375381901","6.56","adcyap1b, adrb1, pdx1, vcam1","INCREASED SECOND MESSENGER PRODUCTION"
"GO:0006412","3","14.3721606641028","0.205288355903327","2.78","eif2s1b, eif4e2rs1, rpl24","ALTERED PROTEIN PRODUCTION"
"GO:0030163","4","16.4903843076508","0.143038051448195","2.61","anapc10, psmb5, psmd4b, ube2ia","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0045333","3","19.7695718541372","0.206539006060182","4.17","cyc1, ndufs6, sirt3","INCREASE OXIDATIVE METABOLISM"
"GO:0019904","5","28.5180702540073","0.0983275462572986","4.07","adrb1, caspa, smad2, u2af2b, ube2ia","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
